Breaking News

Evotec Acquires Galapagos Unit

Evotec AG has acquired Galapagos NV’s Compound Focus, Inc., the compound management business of the Galapagos company BioFocus, for $14.7 million in cash, with an additional $3.2 million in potential milestones.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has acquired Galapagos NV’s Compound Focus, Inc., the compound management business of the Galapagos company BioFocus, for $14.7 million in cash, with an additional $3.2 million in potential milestones. Compound Focus, Inc. is based in South San Francisco and is a leader in small molecule compound management services. The company’s technologies are focused on automated storage and custom design solutions for small molecule drugs. This acquisition augments Evotec’s early drug discover...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters